InvestorsHub Logo
Followers 11
Posts 1199
Boards Moderated 0
Alias Born 01/02/2003

Re: None

Monday, 05/18/2015 2:27:15 PM

Monday, May 18, 2015 2:27:15 PM

Post# of 403096
Dr Shapiro presenting at ASCO.The abstract didn't reveal anything new but he is the head of early drug discovery at Dana Farber and I don't believe he would waste his time or prestige to say little about a new drug candidate that has low toxicity but is ineffective. I believe he will provide some early clinical indications of promise for Kevetrin. This will be exciting.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News